Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03686501 · ClinicalTrials.gov registry record · Early Phase 1
D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562
A Early Phase 1 study, sponsored by Invicro.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT03686501 is a Early Phase 1 study that has completed, run by Invicro. The registered enrollment target is 6 participants.
The verdict
NCT03686501, a Early Phase 1 study, has completed, sponsored by Invicro.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
To assess the D1 receptor occupancy (D1 RO) in striatum after a single oral administration of PF-06412562.
Interventions
- DRUG PF-06412562
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2019-03-28 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03686501
The ClinicalTrials.gov registry entry for NCT03686501 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Invicro, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PF-06412562 is the first listed.
NCT03686501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03686501 about?
NCT03686501 is a clinical study titled "D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562". To assess the D1 receptor occupancy (D1 RO) in striatum after a single oral administration of PF-06412562.
What is the current status of trial NCT03686501?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2018-09-10. Estimated completion is 2019-03-28.
What interventions are being tested in trial NCT03686501?
The interventions under investigation include: PF-06412562 (DRUG).
Who is sponsoring clinical trial NCT03686501?
This trial is sponsored by Invicro, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.